Log in to your Inderes Free account to see all free content on this page.

Swedish Orphan Biovitrum

427.80 SEK

+1.86%

Less than 1K followers

SOBI

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Swedish Orphan Biovitrum

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)147.57158.65176.80206.03267.00317.40332.80
Shares306.4308.1308.1309.9339.8343.4357.4
Market cap45,214.348,883.154,474.763,850.490,715.1109,008.8118,947.0
Enterprise value60,618.363,050.163,974.771,590.4110,296.1124,603.8-
EV/S4.34.14.13.85.04.8-
EV/EBITDA10.29.211.111.515.213.4-
EV/EBIT13.413.117.118.827.122.2-
P/E13.715.120.324.235.727.9239.4
P/B2.672.422.352.412.682.713.15
P/S3.23.23.53.44.14.24.2
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio37.1 %41.8 %47.7 %50.5 %45.7 %53.4 %55.9 %
Gearing ratio97.3 %72.1 %47.0 %34.3 %60.5 %41.5 %30.5 %
Login required

This content is only available for logged in users